

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.02988696 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 7.02988696 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.90806690 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 6.90806690 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 6.38203321 |
| 6 | tryptophan catabolic process (GO:0006569) | 5.86850657 |
| 7 | indole-containing compound catabolic process (GO:0042436) | 5.86850657 |
| 8 | indolalkylamine catabolic process (GO:0046218) | 5.86850657 |
| 9 | kynurenine metabolic process (GO:0070189) | 5.81282645 |
| 10 | cysteine metabolic process (GO:0006534) | 5.71886801 |
| 11 | glyoxylate metabolic process (GO:0046487) | 5.62961098 |
| 12 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.60788876 |
| 13 | tryptophan metabolic process (GO:0006568) | 5.51206100 |
| 14 | bile acid biosynthetic process (GO:0006699) | 5.48827620 |
| 15 | serine family amino acid catabolic process (GO:0009071) | 5.48523026 |
| 16 | sulfur amino acid catabolic process (GO:0000098) | 5.37310859 |
| 17 | urea metabolic process (GO:0019627) | 5.31033106 |
| 18 | urea cycle (GO:0000050) | 5.31033106 |
| 19 | glycine metabolic process (GO:0006544) | 5.28905292 |
| 20 | negative regulation of fibrinolysis (GO:0051918) | 5.27678422 |
| 21 | alpha-linolenic acid metabolic process (GO:0036109) | 5.06573455 |
| 22 | regulation of fibrinolysis (GO:0051917) | 4.98695284 |
| 23 | high-density lipoprotein particle remodeling (GO:0034375) | 4.93405750 |
| 24 | regulation of protein activation cascade (GO:2000257) | 4.91106770 |
| 25 | nitrogen cycle metabolic process (GO:0071941) | 4.89703926 |
| 26 | protein carboxylation (GO:0018214) | 4.88652235 |
| 27 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.88652235 |
| 28 | lysine metabolic process (GO:0006553) | 4.83943620 |
| 29 | lysine catabolic process (GO:0006554) | 4.83943620 |
| 30 | serine family amino acid metabolic process (GO:0009069) | 4.81788961 |
| 31 | serine family amino acid biosynthetic process (GO:0009070) | 4.81552365 |
| 32 | complement activation, alternative pathway (GO:0006957) | 4.75149537 |
| 33 | homocysteine metabolic process (GO:0050667) | 4.74228765 |
| 34 | aromatic amino acid family metabolic process (GO:0009072) | 4.71680159 |
| 35 | bile acid metabolic process (GO:0008206) | 4.65450821 |
| 36 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.65210835 |
| 37 | regulation of complement activation (GO:0030449) | 4.57388670 |
| 38 | amino-acid betaine metabolic process (GO:0006577) | 4.54720719 |
| 39 | alpha-amino acid catabolic process (GO:1901606) | 4.51069071 |
| 40 | imidazole-containing compound metabolic process (GO:0052803) | 4.38446096 |
| 41 | negative regulation of cholesterol transport (GO:0032375) | 4.26938109 |
| 42 | negative regulation of sterol transport (GO:0032372) | 4.26938109 |
| 43 | regulation of triglyceride catabolic process (GO:0010896) | 4.26451165 |
| 44 | tyrosine metabolic process (GO:0006570) | 4.24029242 |
| 45 | acylglycerol homeostasis (GO:0055090) | 4.20242490 |
| 46 | triglyceride homeostasis (GO:0070328) | 4.20242490 |
| 47 | reverse cholesterol transport (GO:0043691) | 4.19519966 |
| 48 | cellular amino acid catabolic process (GO:0009063) | 4.17449704 |
| 49 | regulation of cholesterol esterification (GO:0010872) | 4.16410770 |
| 50 | protein-lipid complex remodeling (GO:0034368) | 4.16392026 |
| 51 | macromolecular complex remodeling (GO:0034367) | 4.16392026 |
| 52 | plasma lipoprotein particle remodeling (GO:0034369) | 4.16392026 |
| 53 | indolalkylamine metabolic process (GO:0006586) | 4.08304389 |
| 54 | cellular modified amino acid catabolic process (GO:0042219) | 4.03744307 |
| 55 | ethanol oxidation (GO:0006069) | 4.03542126 |
| 56 | coenzyme catabolic process (GO:0009109) | 4.02136202 |
| 57 | bile acid and bile salt transport (GO:0015721) | 4.02060412 |
| 58 | amine catabolic process (GO:0009310) | 3.99927955 |
| 59 | cellular biogenic amine catabolic process (GO:0042402) | 3.99927955 |
| 60 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.98309846 |
| 61 | cellular ketone body metabolic process (GO:0046950) | 3.97782192 |
| 62 | glutamate metabolic process (GO:0006536) | 3.90834538 |
| 63 | L-serine metabolic process (GO:0006563) | 3.90077969 |
| 64 | NIK/NF-kappaB signaling (GO:0038061) | 3.89530282 |
| 65 | phospholipid efflux (GO:0033700) | 3.86817825 |
| 66 | benzene-containing compound metabolic process (GO:0042537) | 3.82852829 |
| 67 | plasma lipoprotein particle clearance (GO:0034381) | 3.81725962 |
| 68 | arginine metabolic process (GO:0006525) | 3.69237479 |
| 69 | urate metabolic process (GO:0046415) | 3.67614269 |
| 70 | fibrinolysis (GO:0042730) | 3.67406164 |
| 71 | blood coagulation, intrinsic pathway (GO:0007597) | 3.67217989 |
| 72 | regulation of cholesterol homeostasis (GO:2000188) | 3.65363992 |
| 73 | aldehyde catabolic process (GO:0046185) | 3.65327478 |
| 74 | response to peptidoglycan (GO:0032494) | 3.62885715 |
| 75 | drug catabolic process (GO:0042737) | 3.61768548 |
| 76 | cellular glucuronidation (GO:0052695) | 3.61586415 |
| 77 | carboxylic acid catabolic process (GO:0046395) | 3.58545990 |
| 78 | organic acid catabolic process (GO:0016054) | 3.58545990 |
| 79 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.57587875 |
| 80 | * one-carbon metabolic process (GO:0006730) | 3.56934503 |
| 81 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.54073389 |
| 82 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.53512037 |
| 83 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.53512037 |
| 84 | plasma lipoprotein particle assembly (GO:0034377) | 3.51933551 |
| 85 | 2-oxoglutarate metabolic process (GO:0006103) | 3.51563280 |
| 86 | complement activation, classical pathway (GO:0006958) | 3.50941159 |
| 87 | acetyl-CoA metabolic process (GO:0006084) | 3.49845022 |
| 88 | cholesterol efflux (GO:0033344) | 3.49522046 |
| 89 | response to nitrosative stress (GO:0051409) | 3.46469847 |
| 90 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.45137011 |
| 91 | aspartate family amino acid catabolic process (GO:0009068) | 3.44150741 |
| 92 | heme transport (GO:0015886) | 3.42910882 |
| 93 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.42258328 |
| 94 | pyridine nucleotide biosynthetic process (GO:0019363) | 3.42258328 |
| 95 | ketone body metabolic process (GO:1902224) | 3.41557536 |
| 96 | cofactor catabolic process (GO:0051187) | 3.40944831 |
| 97 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.40457432 |
| 98 | cholesterol homeostasis (GO:0042632) | 3.39349416 |
| 99 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 3.39193834 |
| 100 | complement activation (GO:0006956) | 3.38980483 |
| 101 | pinocytosis (GO:0006907) | 3.37561313 |
| 102 | protein activation cascade (GO:0072376) | 3.35905936 |
| 103 | NAD biosynthetic process (GO:0009435) | 3.35835969 |
| 104 | sterol homeostasis (GO:0055092) | 3.34333698 |
| 105 | cytolysis (GO:0019835) | 3.32945458 |
| 106 | drug transmembrane transport (GO:0006855) | 3.30629725 |
| 107 | low-density lipoprotein particle remodeling (GO:0034374) | 3.30186398 |
| 108 | mature B cell differentiation involved in immune response (GO:0002313) | 3.25172438 |
| 109 | purine nucleotide salvage (GO:0032261) | 3.19429383 |
| 110 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 3.13655012 |
| 111 | response to muramyl dipeptide (GO:0032495) | 3.11365522 |
| 112 | pentose-phosphate shunt (GO:0006098) | 3.09562408 |
| 113 | nucleotide salvage (GO:0043173) | 3.08300832 |
| 114 | immunoglobulin mediated immune response (GO:0016064) | 3.07335511 |
| 115 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.05556304 |
| 116 | activation of MAPKKK activity (GO:0000185) | 3.02094591 |
| 117 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.01220735 |
| 118 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.95459023 |
| 119 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.94761890 |
| 120 | negative regulation of interleukin-12 production (GO:0032695) | 2.90765955 |
| 121 | regulation of vitamin metabolic process (GO:0030656) | 2.88005816 |
| 122 | type I interferon signaling pathway (GO:0060337) | 2.84593780 |
| 123 | cellular response to type I interferon (GO:0071357) | 2.84593780 |
| 124 | regulation of chemokine biosynthetic process (GO:0045073) | 2.82998800 |
| 125 | response to type I interferon (GO:0034340) | 2.82326354 |
| 126 | purine deoxyribonucleotide catabolic process (GO:0009155) | 2.81802072 |
| 127 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.80134093 |
| 128 | modulation by symbiont of host cellular process (GO:0044068) | 2.78731685 |
| 129 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.78081111 |
| 130 | positive regulation of B cell differentiation (GO:0045579) | 2.77402089 |
| 131 | barbed-end actin filament capping (GO:0051016) | 2.75996735 |
| 132 | negative regulation of B cell apoptotic process (GO:0002903) | 2.74217126 |
| 133 | Peyers patch development (GO:0048541) | 2.72391819 |
| 134 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.72391819 |
| 135 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.72106499 |
| 136 | germinal center formation (GO:0002467) | 2.69721474 |
| 137 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.68345890 |
| 138 | mannose metabolic process (GO:0006013) | 2.68136062 |
| 139 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 2.66619643 |
| 140 | UV protection (GO:0009650) | 2.65113800 |
| 141 | Golgi transport vesicle coating (GO:0048200) | 2.63275731 |
| 142 | COPI coating of Golgi vesicle (GO:0048205) | 2.63275731 |
| 143 | negative regulation of cell size (GO:0045792) | 2.62989605 |
| 144 | regulation of monocyte differentiation (GO:0045655) | 2.62078645 |
| 145 | response to protozoan (GO:0001562) | 2.61102046 |
| 146 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.60789364 |
| 147 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.59086978 |
| 148 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.58166515 |
| 149 | positive thymic T cell selection (GO:0045059) | 2.55793934 |
| 150 | NADPH regeneration (GO:0006740) | 2.54417471 |
| 151 | glucose catabolic process (GO:0006007) | 2.54178102 |
| 152 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.49658989 |
| 153 | GDP-mannose metabolic process (GO:0019673) | 2.49261289 |
| 154 | myeloid dendritic cell differentiation (GO:0043011) | 2.48067734 |
| 155 | cellular response to virus (GO:0098586) | 2.47324633 |
| 156 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.45857244 |
| 157 | glycosphingolipid catabolic process (GO:0046479) | 2.45393653 |
| 158 | negative regulation of innate immune response (GO:0045824) | 2.44926034 |
| 159 | regulation of gamma-delta T cell activation (GO:0046643) | 2.44548331 |
| 160 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.43935380 |
| 161 | regulation of B cell apoptotic process (GO:0002902) | 2.43458354 |
| 162 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.43344228 |
| 163 | regulation of necrotic cell death (GO:0010939) | 2.42914888 |
| 164 | negative regulation of tumor necrosis factor production (GO:0032720) | 2.41849540 |
| 165 | defense response to protozoan (GO:0042832) | 2.41121006 |
| 166 | low-density lipoprotein particle clearance (GO:0034383) | 2.40470666 |
| 167 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.39107413 |
| 168 | myeloid dendritic cell activation (GO:0001773) | 2.38036008 |
| 169 | protein localization to endosome (GO:0036010) | 2.37467573 |
| 170 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.37154295 |
| 171 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.36983872 |
| 172 | regulation of superoxide anion generation (GO:0032928) | 2.36384131 |
| 173 | tumor necrosis factor-mediated signaling pathway (GO:0033209) | 2.35811981 |
| 174 | negative regulation of necroptotic process (GO:0060546) | 2.35047634 |
| 175 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.34248394 |
| 176 | modulation by virus of host process (GO:0019054) | 2.33989788 |
| 177 | amino sugar catabolic process (GO:0046348) | 2.33646627 |
| 178 | negative regulation of cell killing (GO:0031342) | 2.33429511 |
| 179 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.33429511 |
| 180 | protein retention in ER lumen (GO:0006621) | 2.32978950 |
| 181 | negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556) | 2.32788275 |
| 182 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.32732996 |
| 183 | regulation of cholesterol storage (GO:0010885) | 2.32677808 |
| 184 | pyrimidine nucleoside salvage (GO:0043097) | 2.31171132 |
| 185 | pyrimidine-containing compound salvage (GO:0008655) | 2.31171132 |
| 186 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.29247885 |
| 187 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.27652907 |
| 188 | neutrophil activation involved in immune response (GO:0002283) | 2.27160478 |
| 189 | B cell mediated immunity (GO:0019724) | 2.26790265 |
| 190 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.25253083 |
| 191 | regulation of antigen processing and presentation (GO:0002577) | 2.24799980 |
| 192 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.24621411 |
| 193 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.23834561 |
| 194 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.23608938 |
| 195 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.23497928 |
| 196 | pentose metabolic process (GO:0019321) | 2.22450228 |
| 197 | regulation of tumor necrosis factor superfamily cytokine production (GO:1903555) | 2.21574960 |
| 198 | response to thyroid hormone (GO:0097066) | 2.21085659 |
| 199 | negative regulation of type I interferon production (GO:0032480) | 2.20969989 |
| 200 | regulation of podosome assembly (GO:0071801) | 2.20787571 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 9.60464078 |
| 2 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.62055978 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.88002967 |
| 4 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.42748149 |
| 5 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.85289714 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.45189546 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.01507313 |
| 8 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.83604717 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.73689096 |
| 10 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.03096576 |
| 11 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.79220907 |
| 12 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.65663775 |
| 13 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.45715185 |
| 14 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.27877119 |
| 15 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.27022909 |
| 16 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.25142439 |
| 17 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.22466415 |
| 18 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.12553213 |
| 19 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.01153287 |
| 20 | * MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.94022836 |
| 21 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.93236527 |
| 22 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.89205249 |
| 23 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.87696869 |
| 24 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.83205320 |
| 25 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.74666214 |
| 26 | MAF_26560356_Chip-Seq_TH1_Human | 1.73904253 |
| 27 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.73232875 |
| 28 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.73127725 |
| 29 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.72668832 |
| 30 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.67088050 |
| 31 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.62032194 |
| 32 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.61577074 |
| 33 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.56762178 |
| 34 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.56725938 |
| 35 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.54748486 |
| 36 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.53670007 |
| 37 | MAF_26560356_Chip-Seq_TH2_Human | 1.53335434 |
| 38 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.53308391 |
| 39 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.50986797 |
| 40 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.50036466 |
| 41 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.49680037 |
| 42 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.48250615 |
| 43 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.48150301 |
| 44 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.46970096 |
| 45 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.44046045 |
| 46 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.43905131 |
| 47 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.43262392 |
| 48 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.41991655 |
| 49 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.40352572 |
| 50 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.39651052 |
| 51 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.38838144 |
| 52 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.37702227 |
| 53 | * P68_20966046_ChIP-Seq_HELA_Human | 1.37340789 |
| 54 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.34967274 |
| 55 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.31746128 |
| 56 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.30116560 |
| 57 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.29773929 |
| 58 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.29623673 |
| 59 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.29296125 |
| 60 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.29237698 |
| 61 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.29122327 |
| 62 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.28772104 |
| 63 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.28186993 |
| 64 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.27842513 |
| 65 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.27749461 |
| 66 | * FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.27523032 |
| 67 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.26102127 |
| 68 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.26008744 |
| 69 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.25115987 |
| 70 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.23341283 |
| 71 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.23248875 |
| 72 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.22746730 |
| 73 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.21967226 |
| 74 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.20854330 |
| 75 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.20400796 |
| 76 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.19694207 |
| 77 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.19289907 |
| 78 | * RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.18771360 |
| 79 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.18161871 |
| 80 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.17492831 |
| 81 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.16859375 |
| 82 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.15620879 |
| 83 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.14910139 |
| 84 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.13980896 |
| 85 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.13889229 |
| 86 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.12528827 |
| 87 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.12277697 |
| 88 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.12071364 |
| 89 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.10626171 |
| 90 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.10518224 |
| 91 | * NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.09843132 |
| 92 | GATA1_22025678_ChIP-Seq_K562_Human | 1.09226940 |
| 93 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.08552509 |
| 94 | * MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.06087515 |
| 95 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.05415893 |
| 96 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.05340520 |
| 97 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.04524579 |
| 98 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.03982374 |
| 99 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.03764162 |
| 100 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.02903980 |
| 101 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.00932425 |
| 102 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.00543501 |
| 103 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.00432013 |
| 104 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.00176099 |
| 105 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.99087005 |
| 106 | DCP1A_22483619_ChIP-Seq_HELA_Human | 0.98796762 |
| 107 | * SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.97862126 |
| 108 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.97527803 |
| 109 | XRN2_22483619_ChIP-Seq_HELA_Human | 0.97338780 |
| 110 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.97217939 |
| 111 | MYC_22102868_ChIP-Seq_BL_Human | 0.93355049 |
| 112 | GABP_19822575_ChIP-Seq_HepG2_Human | 0.93070751 |
| 113 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 0.91904473 |
| 114 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 0.91871726 |
| 115 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.91762077 |
| 116 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 0.90750696 |
| 117 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.90162544 |
| 118 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 0.88770702 |
| 119 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.88431776 |
| 120 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 0.88327422 |
| 121 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.88189805 |
| 122 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.88061868 |
| 123 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.87212310 |
| 124 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.85266670 |
| 125 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 0.84879223 |
| 126 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.84566292 |
| 127 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.84062125 |
| 128 | * KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.81628497 |
| 129 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.80523988 |
| 130 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.79177106 |
| 131 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.79063572 |
| 132 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.78134798 |
| 133 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.76291251 |
| 134 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 0.75579425 |
| 135 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.75265899 |
| 136 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.74619552 |
| 137 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.73258485 |
| 138 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.72215931 |
| 139 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.70649181 |
| 140 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.69791307 |
| 141 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 0.69618579 |
| 142 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.69526361 |
| 143 | * OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.68974773 |
| 144 | * ATF3_27146783_Chip-Seq_COLON_Human | 0.68371491 |
| 145 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.68244569 |
| 146 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.65708502 |
| 147 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.65120249 |
| 148 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 0.64904811 |
| 149 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 0.64776336 |
| 150 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.63469009 |
| 151 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.62805007 |
| 152 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.61962891 |
| 153 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.61595639 |
| 154 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.61470919 |
| 155 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.61300402 |
| 156 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.59407048 |
| 157 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 0.59219129 |
| 158 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.58521441 |
| 159 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.58480550 |
| 160 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.58113256 |
| 161 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.57809354 |
| 162 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.56964187 |
| 163 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.55033270 |
| 164 | * CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.54755160 |
| 165 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.54659304 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.68965305 |
| 2 | MP0005360_urolithiasis | 7.03171183 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.92424033 |
| 4 | MP0005365_abnormal_bile_salt | 5.83394353 |
| 5 | MP0003806_abnormal_nucleotide_metabolis | 4.77592528 |
| 6 | MP0008875_abnormal_xenobiotic_pharmacok | 4.49816476 |
| 7 | MP0003252_abnormal_bile_duct | 3.57392414 |
| 8 | MP0003303_peritoneal_inflammation | 3.38643703 |
| 9 | MP0009840_abnormal_foam_cell | 3.31368584 |
| 10 | MP0005058_abnormal_lysosome_morphology | 3.29017261 |
| 11 | MP0010329_abnormal_lipoprotein_level | 3.16659725 |
| 12 | MP0005083_abnormal_biliary_tract | 2.92775319 |
| 13 | MP0009278_abnormal_bone_marrow | 2.72135940 |
| 14 | MP0005332_abnormal_amino_acid | 2.69686269 |
| 15 | MP0001835_abnormal_antigen_presentation | 2.51835360 |
| 16 | MP0001666_abnormal_nutrient_absorption | 2.49506346 |
| 17 | MP0002148_abnormal_hypersensitivity_rea | 2.39327496 |
| 18 | MP0003195_calcinosis | 2.38423793 |
| 19 | MP0005000_abnormal_immune_tolerance | 2.23794218 |
| 20 | MP0003191_abnormal_cellular_cholesterol | 2.14689104 |
| 21 | MP0000609_abnormal_liver_physiology | 2.14326290 |
| 22 | MP0001545_abnormal_hematopoietic_system | 2.12917305 |
| 23 | MP0005025_abnormal_response_to | 2.12569775 |
| 24 | MP0009785_altered_susceptibility_to | 2.10710864 |
| 25 | MP0000685_abnormal_immune_system | 2.03087406 |
| 26 | MP0009333_abnormal_splenocyte_physiolog | 2.03081488 |
| 27 | MP0004019_abnormal_vitamin_homeostasis | 2.01117848 |
| 28 | MP0004510_myositis | 2.01095640 |
| 29 | MP0005387_immune_system_phenotype | 1.96677584 |
| 30 | MP0001790_abnormal_immune_system | 1.96677584 |
| 31 | MP0003300_gastrointestinal_ulcer | 1.95396656 |
| 32 | MP0002419_abnormal_innate_immunity | 1.94871306 |
| 33 | MP0003763_abnormal_thymus_physiology | 1.93425457 |
| 34 | MP0004947_skin_inflammation | 1.90127880 |
| 35 | MP0005319_abnormal_enzyme/_coenzyme | 1.83517819 |
| 36 | MP0005451_abnormal_body_composition | 1.82917766 |
| 37 | MP0002118_abnormal_lipid_homeostasis | 1.82207805 |
| 38 | MP0002723_abnormal_immune_serum | 1.80170341 |
| 39 | MP0002138_abnormal_hepatobiliary_system | 1.79878633 |
| 40 | MP0002452_abnormal_antigen_presenting | 1.78459341 |
| 41 | MP0003724_increased_susceptibility_to | 1.78029308 |
| 42 | MP0005671_abnormal_response_to | 1.78019277 |
| 43 | MP0000858_altered_metastatic_potential | 1.78015649 |
| 44 | MP0003868_abnormal_feces_composition | 1.74255396 |
| 45 | MP0001800_abnormal_humoral_immune | 1.70952205 |
| 46 | MP0003705_abnormal_hypodermis_morpholog | 1.70935282 |
| 47 | MP0001764_abnormal_homeostasis | 1.69293402 |
| 48 | MP0001819_abnormal_immune_cell | 1.65135952 |
| 49 | MP0002420_abnormal_adaptive_immunity | 1.64707190 |
| 50 | MP0001533_abnormal_skeleton_physiology | 1.63835654 |
| 51 | MP0003186_abnormal_redox_activity | 1.55715463 |
| 52 | MP0003075_altered_response_to | 1.51716987 |
| 53 | MP0006082_CNS_inflammation | 1.51343069 |
| 54 | MP0004185_abnormal_adipocyte_glucose | 1.50554979 |
| 55 | MP0003172_abnormal_lysosome_physiology | 1.46717371 |
| 56 | MP0001849_ear_inflammation | 1.45767339 |
| 57 | MP0002398_abnormal_bone_marrow | 1.45721473 |
| 58 | MP0008260_abnormal_autophagy | 1.45124158 |
| 59 | MP0003656_abnormal_erythrocyte_physiolo | 1.45118687 |
| 60 | MP0010155_abnormal_intestine_physiology | 1.43429098 |
| 61 | MP0003718_maternal_effect | 1.38878379 |
| 62 | MP0000343_altered_response_to | 1.37853425 |
| 63 | MP0000716_abnormal_immune_system | 1.37119650 |
| 64 | MP0002877_abnormal_melanocyte_morpholog | 1.36822717 |
| 65 | MP0002405_respiratory_system_inflammati | 1.35227594 |
| 66 | MP0005076_abnormal_cell_differentiation | 1.35017047 |
| 67 | MP0009643_abnormal_urine_homeostasis | 1.34712831 |
| 68 | MP0001845_abnormal_inflammatory_respons | 1.33878498 |
| 69 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.32463491 |
| 70 | MP0002722_abnormal_immune_system | 1.32135379 |
| 71 | MP0000598_abnormal_liver_morphology | 1.31932965 |
| 72 | MP0009697_abnormal_copulation | 1.31259487 |
| 73 | MP0004808_abnormal_hematopoietic_stem | 1.29423387 |
| 74 | MP0002429_abnormal_blood_cell | 1.27284456 |
| 75 | MP0001873_stomach_inflammation | 1.25212811 |
| 76 | MP0002396_abnormal_hematopoietic_system | 1.22400193 |
| 77 | MP0000689_abnormal_spleen_morphology | 1.19670390 |
| 78 | MP0005647_abnormal_sex_gland | 1.15086318 |
| 79 | MP0003011_delayed_dark_adaptation | 1.14835824 |
| 80 | MP0000465_gastrointestinal_hemorrhage | 1.14783722 |
| 81 | MP0003448_altered_tumor_morphology | 1.14269440 |
| 82 | MP0002998_abnormal_bone_remodeling | 1.12291376 |
| 83 | MP0002933_joint_inflammation | 1.08430545 |
| 84 | MP0000490_abnormal_crypts_of | 1.06396556 |
| 85 | MP0003279_aneurysm | 1.05577852 |
| 86 | MP0006036_abnormal_mitochondrial_physio | 1.04638508 |
| 87 | MP0005220_abnormal_exocrine_pancreas | 1.04090004 |
| 88 | MP0002332_abnormal_exercise_endurance | 1.03895625 |
| 89 | MP0005375_adipose_tissue_phenotype | 1.02911877 |
| 90 | MP0000703_abnormal_thymus_morphology | 1.01661591 |
| 91 | MP0004858_abnormal_nervous_system | 1.00971183 |
| 92 | MP0005636_abnormal_mineral_homeostasis | 0.99044609 |
| 93 | MP0005165_increased_susceptibility_to | 0.98209943 |
| 94 | MP0009763_increased_sensitivity_to | 0.98143840 |
| 95 | MP0005166_decreased_susceptibility_to | 0.96532772 |
| 96 | MP0003091_abnormal_cell_migration | 0.95235469 |
| 97 | MP0008438_abnormal_cutaneous_collagen | 0.94796593 |
| 98 | MP0003693_abnormal_embryo_hatching | 0.94222988 |
| 99 | MP0005390_skeleton_phenotype | 0.93425786 |
| 100 | MP0005408_hypopigmentation | 0.93116861 |
| 101 | MP0003566_abnormal_cell_adhesion | 0.92607608 |
| 102 | MP0010368_abnormal_lymphatic_system | 0.87961367 |
| 103 | MP0000750_abnormal_muscle_regeneration | 0.83195943 |
| 104 | MP0008469_abnormal_protein_level | 0.81414414 |
| 105 | MP0005395_other_phenotype | 0.81287258 |
| 106 | MP0000003_abnormal_adipose_tissue | 0.80102418 |
| 107 | MP0005310_abnormal_salivary_gland | 0.80066358 |
| 108 | MP0009642_abnormal_blood_homeostasis | 0.78965129 |
| 109 | MP0009764_decreased_sensitivity_to | 0.78716897 |
| 110 | MP0005670_abnormal_white_adipose | 0.78713189 |
| 111 | MP0005376_homeostasis/metabolism_phenot | 0.78588191 |
| 112 | MP0005266_abnormal_metabolism | 0.78046873 |
| 113 | MP0009053_abnormal_anal_canal | 0.77000066 |
| 114 | MP0001542_abnormal_bone_strength | 0.76243977 |
| 115 | MP0006035_abnormal_mitochondrial_morpho | 0.74744229 |
| 116 | MP0004264_abnormal_extraembryonic_tissu | 0.73591053 |
| 117 | MP0009765_abnormal_xenobiotic_induced | 0.73451626 |
| 118 | MP0005084_abnormal_gallbladder_morpholo | 0.72865779 |
| 119 | MP0008007_abnormal_cellular_replicative | 0.72151111 |
| 120 | MP0005621_abnormal_cell_physiology | 0.71899281 |
| 121 | MP0004233_abnormal_muscle_weight | 0.71148586 |
| 122 | MP0009931_abnormal_skin_appearance | 0.70701831 |
| 123 | MP0003795_abnormal_bone_structure | 0.70364060 |
| 124 | MP0003329_amyloid_beta_deposits | 0.69640148 |
| 125 | MP0001756_abnormal_urination | 0.68007806 |
| 126 | MP0002254_reproductive_system_inflammat | 0.67429993 |
| 127 | MP0004957_abnormal_blastocyst_morpholog | 0.66720093 |
| 128 | MP0009672_abnormal_birth_weight | 0.64923243 |
| 129 | MP0002078_abnormal_glucose_homeostasis | 0.62566887 |
| 130 | MP0000604_amyloidosis | 0.61480765 |
| 131 | MP0001661_extended_life_span | 0.60961820 |
| 132 | MP0003111_abnormal_nucleus_morphology | 0.57034658 |
| 133 | MP0002136_abnormal_kidney_physiology | 0.55980217 |
| 134 | MP0005334_abnormal_fat_pad | 0.52769288 |
| 135 | MP0005023_abnormal_wound_healing | 0.52251632 |
| 136 | MP0002132_abnormal_respiratory_system | 0.52245336 |
| 137 | MP0001915_intracranial_hemorrhage | 0.50917708 |
| 138 | MP0008873_increased_physiological_sensi | 0.50818247 |
| 139 | MP0002971_abnormal_brown_adipose | 0.50624174 |
| 140 | MP0003699_abnormal_female_reproductive | 0.48538912 |
| 141 | MP0001730_embryonic_growth_arrest | 0.48460738 |
| 142 | MP0000639_abnormal_adrenal_gland | 0.48438282 |
| 143 | MP0010094_abnormal_chromosome_stability | 0.45919247 |
| 144 | MP0002796_impaired_skin_barrier | 0.44798879 |
| 145 | MP0005464_abnormal_platelet_physiology | 0.44608625 |
| 146 | MP0001243_abnormal_dermal_layer | 0.44128646 |
| 147 | MP0003077_abnormal_cell_cycle | 0.43677579 |
| 148 | MP0002970_abnormal_white_adipose | 0.42708853 |
| 149 | MP0010352_gastrointestinal_tract_polyps | 0.40283472 |
| 150 | MP0005666_abnormal_adipose_tissue | 0.38726441 |
| 151 | MP0001119_abnormal_female_reproductive | 0.38533258 |
| 152 | MP0003436_decreased_susceptibility_to | 0.38476775 |
| 153 | MP0002928_abnormal_bile_duct | 0.37558619 |
| 154 | MP0010234_abnormal_vibrissa_follicle | 0.37456415 |
| 155 | MP0003638_abnormal_response/metabolism_ | 0.35935147 |
| 156 | MP0002269_muscular_atrophy | 0.35388998 |
| 157 | MP0001853_heart_inflammation | 0.35185014 |
| 158 | MP0002135_abnormal_kidney_morphology | 0.34575954 |
| 159 | MP0005075_abnormal_melanosome_morpholog | 0.34166329 |
| 160 | MP0002060_abnormal_skin_morphology | 0.33910935 |
| 161 | MP0002019_abnormal_tumor_incidence | 0.33365994 |
| 162 | MP0002086_abnormal_extraembryonic_tissu | 0.32727027 |
| 163 | MP0001672_abnormal_embryogenesis/_devel | 0.32572137 |
| 164 | MP0005380_embryogenesis_phenotype | 0.32572137 |
| 165 | MP0005448_abnormal_energy_balance | 0.31894793 |
| 166 | MP0003453_abnormal_keratinocyte_physiol | 0.31835521 |
| 167 | MP0000579_abnormal_nail_morphology | 0.31822278 |
| 168 | MP0009115_abnormal_fat_cell | 0.31571826 |
| 169 | MP0000358_abnormal_cell_content/ | 0.31560349 |
| 170 | MP0001881_abnormal_mammary_gland | 0.30867215 |
| 171 | MP0003953_abnormal_hormone_level | 0.30618608 |
| 172 | MP0005501_abnormal_skin_physiology | 0.29957071 |
| 173 | MP0005397_hematopoietic_system_phenotyp | 0.29765995 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.19600846 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 7.12847366 |
| 3 | Deep venous thrombosis (HP:0002625) | 7.04531647 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.63123062 |
| 5 | Hypobetalipoproteinemia (HP:0003563) | 6.22430948 |
| 6 | Prolonged partial thromboplastin time (HP:0003645) | 5.86338068 |
| 7 | Xanthomatosis (HP:0000991) | 5.83249736 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 4.94201100 |
| 9 | Hyperglycinemia (HP:0002154) | 4.79696062 |
| 10 | Complement deficiency (HP:0004431) | 4.74772043 |
| 11 | Hyperammonemia (HP:0001987) | 4.68250270 |
| 12 | Hypolipoproteinemia (HP:0010981) | 4.55391287 |
| 13 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.47321317 |
| 14 | Abnormality of pyrimidine metabolism (HP:0004353) | 4.37506811 |
| 15 | Hyperglycinuria (HP:0003108) | 4.31571729 |
| 16 | Abnormality of methionine metabolism (HP:0010901) | 4.26170062 |
| 17 | Joint hemorrhage (HP:0005261) | 4.18781162 |
| 18 | Abnormality of glycine metabolism (HP:0010895) | 4.17452652 |
| 19 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.17452652 |
| 20 | Abnormality of the common coagulation pathway (HP:0010990) | 4.16678797 |
| 21 | Abnormality of glycolipid metabolism (HP:0010969) | 4.13428929 |
| 22 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.13428929 |
| 23 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.13428929 |
| 24 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.10386316 |
| 25 | Ketosis (HP:0001946) | 4.10044522 |
| 26 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.06069978 |
| 27 | Fat malabsorption (HP:0002630) | 3.96646192 |
| 28 | Epidermoid cyst (HP:0200040) | 3.95350871 |
| 29 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.86204702 |
| 30 | Hypoalphalipoproteinemia (HP:0003233) | 3.85847020 |
| 31 | Abnormality of the intrinsic pathway (HP:0010989) | 3.85509221 |
| 32 | Hypoglycemic coma (HP:0001325) | 3.73925993 |
| 33 | Abnormality of complement system (HP:0005339) | 3.51777896 |
| 34 | Abnormality of serum amino acid levels (HP:0003112) | 3.37337673 |
| 35 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.35768055 |
| 36 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.34754552 |
| 37 | Abnormality of nucleobase metabolism (HP:0010932) | 3.32757474 |
| 38 | Hyperbilirubinemia (HP:0002904) | 3.30422176 |
| 39 | Delayed CNS myelination (HP:0002188) | 3.27341228 |
| 40 | Dysostosis multiplex (HP:0000943) | 3.27145830 |
| 41 | Loss of speech (HP:0002371) | 3.20604937 |
| 42 | Conjugated hyperbilirubinemia (HP:0002908) | 3.15645751 |
| 43 | Hypercholesterolemia (HP:0003124) | 3.12857913 |
| 44 | Steatorrhea (HP:0002570) | 3.05692552 |
| 45 | Ragged-red muscle fibers (HP:0003200) | 3.04511150 |
| 46 | Vertebral compression fractures (HP:0002953) | 3.00590768 |
| 47 | Increased cerebral lipofuscin (HP:0011813) | 2.95036292 |
| 48 | Hepatocellular carcinoma (HP:0001402) | 2.94765843 |
| 49 | Gout (HP:0001997) | 2.93985199 |
| 50 | Spastic diplegia (HP:0001264) | 2.90149248 |
| 51 | Hypochromic microcytic anemia (HP:0004840) | 2.84333681 |
| 52 | Ketoacidosis (HP:0001993) | 2.82663615 |
| 53 | Abnormality of purine metabolism (HP:0004352) | 2.80382806 |
| 54 | Spontaneous abortion (HP:0005268) | 2.78024838 |
| 55 | Myocardial infarction (HP:0001658) | 2.75987811 |
| 56 | Lethargy (HP:0001254) | 2.74043241 |
| 57 | Cellulitis (HP:0100658) | 2.73931284 |
| 58 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.72568107 |
| 59 | Dicarboxylic aciduria (HP:0003215) | 2.72568107 |
| 60 | Metabolic acidosis (HP:0001942) | 2.68817171 |
| 61 | Malnutrition (HP:0004395) | 2.67104439 |
| 62 | Mediastinal lymphadenopathy (HP:0100721) | 2.63634739 |
| 63 | Eczematoid dermatitis (HP:0000976) | 2.63061711 |
| 64 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.62303911 |
| 65 | Abnormality of macrophages (HP:0004311) | 2.57355803 |
| 66 | Agammaglobulinemia (HP:0004432) | 2.54162023 |
| 67 | Recurrent viral infections (HP:0004429) | 2.54058884 |
| 68 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.53440616 |
| 69 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.52364380 |
| 70 | Vacuolated lymphocytes (HP:0001922) | 2.50704657 |
| 71 | Hepatosplenomegaly (HP:0001433) | 2.50597712 |
| 72 | Hypertensive crisis (HP:0100735) | 2.50030355 |
| 73 | Petechiae (HP:0000967) | 2.49169458 |
| 74 | Myositis (HP:0100614) | 2.48662061 |
| 75 | Achilles tendon contracture (HP:0001771) | 2.47332195 |
| 76 | Interstitial pulmonary disease (HP:0006530) | 2.45910032 |
| 77 | Distal lower limb muscle weakness (HP:0009053) | 2.44176387 |
| 78 | Skin nodule (HP:0200036) | 2.39415970 |
| 79 | Acanthocytosis (HP:0001927) | 2.36979186 |
| 80 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.35535490 |
| 81 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.35535490 |
| 82 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.35535490 |
| 83 | Autoimmune thrombocytopenia (HP:0001973) | 2.33917019 |
| 84 | Recurrent abscess formation (HP:0002722) | 2.32500601 |
| 85 | Neonatal onset (HP:0003623) | 2.32327372 |
| 86 | Irritability (HP:0000737) | 2.31967525 |
| 87 | Vascular calcification (HP:0004934) | 2.28082748 |
| 88 | Thoracic kyphosis (HP:0002942) | 2.27706641 |
| 89 | Nuclear cataract (HP:0100018) | 2.27421128 |
| 90 | Late onset (HP:0003584) | 2.27250613 |
| 91 | Brushfield spots (HP:0001088) | 2.27207639 |
| 92 | Polygenic inheritance (HP:0010982) | 2.26326544 |
| 93 | Mucopolysacchariduria (HP:0008155) | 2.26124099 |
| 94 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.26124099 |
| 95 | Colitis (HP:0002583) | 2.24840672 |
| 96 | Cholecystitis (HP:0001082) | 2.22997678 |
| 97 | Abnormal gallbladder physiology (HP:0012438) | 2.22997678 |
| 98 | Recurrent bacterial skin infections (HP:0005406) | 2.22509313 |
| 99 | Distal lower limb amyotrophy (HP:0008944) | 2.22218746 |
| 100 | Progressive muscle weakness (HP:0003323) | 2.21883709 |
| 101 | Progressive neurologic deterioration (HP:0002344) | 2.20572767 |
| 102 | Cerebral edema (HP:0002181) | 2.19606928 |
| 103 | Abnormal cartilage morphology (HP:0002763) | 2.19535087 |
| 104 | Abnormal gallbladder morphology (HP:0012437) | 2.19325775 |
| 105 | Cholelithiasis (HP:0001081) | 2.18227520 |
| 106 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.17389862 |
| 107 | Esophageal varix (HP:0002040) | 2.17004456 |
| 108 | Recurrent fungal infections (HP:0002841) | 2.16729729 |
| 109 | Increased IgM level (HP:0003496) | 2.16729720 |
| 110 | Hypoglycemic seizures (HP:0002173) | 2.15900144 |
| 111 | Increased IgE level (HP:0003212) | 2.15728658 |
| 112 | Abnormality of iron homeostasis (HP:0011031) | 2.15254372 |
| 113 | B lymphocytopenia (HP:0010976) | 2.14476842 |
| 114 | Gastrointestinal stroma tumor (HP:0100723) | 2.13010064 |
| 115 | Generalized aminoaciduria (HP:0002909) | 2.12464373 |
| 116 | Axonal loss (HP:0003447) | 2.11891411 |
| 117 | Orchitis (HP:0100796) | 2.10627227 |
| 118 | Pancreatitis (HP:0001733) | 2.09938675 |
| 119 | Prolonged neonatal jaundice (HP:0006579) | 2.08748683 |
| 120 | Systemic lupus erythematosus (HP:0002725) | 2.08668164 |
| 121 | Hypergammaglobulinemia (HP:0010702) | 2.08318947 |
| 122 | Asymmetric septal hypertrophy (HP:0001670) | 2.08204868 |
| 123 | Opisthotonus (HP:0002179) | 2.07796717 |
| 124 | Meningitis (HP:0001287) | 2.07308631 |
| 125 | Hypertriglyceridemia (HP:0002155) | 2.05670959 |
| 126 | Thrombophlebitis (HP:0004418) | 2.05644072 |
| 127 | Myopathic facies (HP:0002058) | 2.05610987 |
| 128 | Chronic obstructive pulmonary disease (HP:0006510) | 2.03885641 |
| 129 | Obstructive lung disease (HP:0006536) | 2.03885641 |
| 130 | Abnormality of the thoracic spine (HP:0100711) | 2.03195664 |
| 131 | Cardiovascular calcification (HP:0011915) | 1.99572295 |
| 132 | Rough bone trabeculation (HP:0100670) | 1.98839939 |
| 133 | Purpura (HP:0000979) | 1.98662292 |
| 134 | Vomiting (HP:0002013) | 1.98236462 |
| 135 | Poikilocytosis (HP:0004447) | 1.97216794 |
| 136 | Protrusio acetabuli (HP:0003179) | 1.96867338 |
| 137 | Bulbar palsy (HP:0001283) | 1.95298267 |
| 138 | J-shaped sella turcica (HP:0002680) | 1.94621067 |
| 139 | Thin bony cortex (HP:0002753) | 1.94234590 |
| 140 | Upper motor neuron abnormality (HP:0002127) | 1.93937433 |
| 141 | Granulocytopenia (HP:0001913) | 1.93601763 |
| 142 | Hyperacusis (HP:0010780) | 1.93453639 |
| 143 | Increased purine levels (HP:0004368) | 1.93187611 |
| 144 | Hyperuricemia (HP:0002149) | 1.93187611 |
| 145 | Increased connective tissue (HP:0009025) | 1.92553848 |
| 146 | Rhabdomyolysis (HP:0003201) | 1.92072619 |
| 147 | Gingival bleeding (HP:0000225) | 1.92071385 |
| 148 | Fatigue (HP:0012378) | 1.91656517 |
| 149 | Enlarged kidneys (HP:0000105) | 1.91599213 |
| 150 | Joint stiffness (HP:0001387) | 1.91424179 |
| 151 | Glomerulonephritis (HP:0000099) | 1.90555230 |
| 152 | Premature rupture of membranes (HP:0001788) | 1.90526254 |
| 153 | Menorrhagia (HP:0000132) | 1.89922082 |
| 154 | Gastrointestinal inflammation (HP:0004386) | 1.88278101 |
| 155 | Sensorimotor neuropathy (HP:0007141) | 1.88235690 |
| 156 | Reticulocytosis (HP:0001923) | 1.88156852 |
| 157 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.85567846 |
| 158 | Thrombocytosis (HP:0001894) | 1.85392313 |
| 159 | Increased serum ferritin (HP:0003281) | 1.83900005 |
| 160 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.83153795 |
| 161 | Exercise-induced myalgia (HP:0003738) | 1.83001567 |
| 162 | Stomatitis (HP:0010280) | 1.82821246 |
| 163 | Abnormality of the gallbladder (HP:0005264) | 1.81494713 |
| 164 | Panhypogammaglobulinemia (HP:0003139) | 1.81041277 |
| 165 | Proximal tubulopathy (HP:0000114) | 1.80989270 |
| 166 | Trismus (HP:0000211) | 1.80459487 |
| 167 | Abnormality of B cell number (HP:0010975) | 1.80318907 |
| 168 | Elevated hepatic transaminases (HP:0002910) | 1.80317395 |
| 169 | IgA deficiency (HP:0002720) | 1.80149164 |
| 170 | Microvesicular hepatic steatosis (HP:0001414) | 1.78589302 |
| 171 | Emphysema (HP:0002097) | 1.77534012 |
| 172 | Abnormal trabecular bone morphology (HP:0100671) | 1.77355656 |
| 173 | Rickets (HP:0002748) | 1.76746980 |
| 174 | Megaloblastic anemia (HP:0001889) | 1.75060029 |
| 175 | Amyloidosis (HP:0011034) | 1.74455912 |
| 176 | Increased muscle lipid content (HP:0009058) | 1.74240170 |
| 177 | Abnormality of the Achilles tendon (HP:0005109) | 1.73221354 |
| 178 | Nausea (HP:0002018) | 1.72296229 |
| 179 | Mitral stenosis (HP:0001718) | 1.71616164 |
| 180 | Hemorrhage of the eye (HP:0011885) | 1.69855764 |
| 181 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.67344287 |
| 182 | Hyperglycemia (HP:0003074) | 1.66348634 |
| 183 | Autoimmune hemolytic anemia (HP:0001890) | 1.64470818 |
| 184 | Cervical subluxation (HP:0003308) | 1.64169662 |
| 185 | Retrobulbar optic neuritis (HP:0100654) | 1.64144105 |
| 186 | Optic neuritis (HP:0100653) | 1.64144105 |
| 187 | Vasculitis (HP:0002633) | 1.63102182 |
| 188 | Combined immunodeficiency (HP:0005387) | 1.62560828 |
| 189 | Generalized amyotrophy (HP:0003700) | 1.61934814 |
| 190 | Inflammation of the large intestine (HP:0002037) | 1.61536865 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 6.15984157 |
| 2 | ERN1 | 4.24229632 |
| 3 | FGFR4 | 3.20993125 |
| 4 | TAOK3 | 3.07617881 |
| 5 | SIK1 | 2.81151162 |
| 6 | PRPF4B | 2.79279700 |
| 7 | PKN2 | 2.70616232 |
| 8 | PIM2 | 2.59173853 |
| 9 | LATS1 | 2.53139228 |
| 10 | SMG1 | 2.46990474 |
| 11 | TRIB3 | 2.26224581 |
| 12 | FLT3 | 2.22033462 |
| 13 | ERBB4 | 2.19893973 |
| 14 | TESK1 | 2.00658250 |
| 15 | EIF2AK1 | 1.73735519 |
| 16 | MAP3K14 | 1.64563932 |
| 17 | MAP3K10 | 1.63298274 |
| 18 | MAPK11 | 1.63217215 |
| 19 | ARAF | 1.61458741 |
| 20 | STK38L | 1.60779781 |
| 21 | EEF2K | 1.59972032 |
| 22 | BUB1 | 1.59454824 |
| 23 | TTK | 1.58262385 |
| 24 | VRK2 | 1.57372478 |
| 25 | WEE1 | 1.54615509 |
| 26 | LATS2 | 1.45235446 |
| 27 | NEK2 | 1.43488432 |
| 28 | KDR | 1.42883969 |
| 29 | JAK3 | 1.40900847 |
| 30 | NEK1 | 1.40752465 |
| 31 | TTN | 1.38781960 |
| 32 | NME2 | 1.36908681 |
| 33 | CDK4 | 1.34074816 |
| 34 | MAP2K3 | 1.33921301 |
| 35 | IRAK4 | 1.33870461 |
| 36 | EPHA2 | 1.32128164 |
| 37 | TYK2 | 1.30173072 |
| 38 | ICK | 1.26693195 |
| 39 | ABL2 | 1.20428246 |
| 40 | MAPKAPK3 | 1.18609880 |
| 41 | ACVR1B | 1.18007840 |
| 42 | IKBKE | 1.17030110 |
| 43 | MAP3K11 | 1.16151844 |
| 44 | ZAP70 | 1.13261053 |
| 45 | IKBKB | 1.12910791 |
| 46 | CDC7 | 1.11989165 |
| 47 | DYRK3 | 1.10536054 |
| 48 | CDK12 | 1.10329683 |
| 49 | MAP3K13 | 1.10148009 |
| 50 | PTK6 | 1.09743384 |
| 51 | PIK3CG | 1.09713785 |
| 52 | MAP3K8 | 1.05618137 |
| 53 | MAP3K3 | 1.04970544 |
| 54 | STK10 | 1.03222414 |
| 55 | RIPK1 | 1.00619493 |
| 56 | INSRR | 0.98672585 |
| 57 | RPS6KB2 | 0.98306341 |
| 58 | CDK7 | 0.96078165 |
| 59 | TESK2 | 0.95855486 |
| 60 | PLK4 | 0.95480764 |
| 61 | MATK | 0.94462427 |
| 62 | MAP3K1 | 0.92222276 |
| 63 | GRK6 | 0.90198673 |
| 64 | IRAK2 | 0.88049523 |
| 65 | KIT | 0.85508804 |
| 66 | BLK | 0.85335993 |
| 67 | MTOR | 0.84331449 |
| 68 | CDK6 | 0.83542023 |
| 69 | GRK7 | 0.83388335 |
| 70 | DDR2 | 0.82534580 |
| 71 | RPS6KA4 | 0.82224678 |
| 72 | NEK9 | 0.81765923 |
| 73 | MAP2K4 | 0.81607782 |
| 74 | STK3 | 0.80843598 |
| 75 | MAP3K6 | 0.80083345 |
| 76 | MOS | 0.79847866 |
| 77 | CDC42BPA | 0.79286336 |
| 78 | EIF2AK3 | 0.78772582 |
| 79 | PLK1 | 0.77658155 |
| 80 | JAK2 | 0.76271425 |
| 81 | MST1R | 0.75743573 |
| 82 | BTK | 0.75165610 |
| 83 | LIMK1 | 0.73598697 |
| 84 | BMX | 0.72482826 |
| 85 | TGFBR2 | 0.71779887 |
| 86 | STK16 | 0.69103921 |
| 87 | SYK | 0.67761027 |
| 88 | AURKB | 0.67653901 |
| 89 | AURKA | 0.67301554 |
| 90 | LRRK2 | 0.65463917 |
| 91 | TAOK1 | 0.65342613 |
| 92 | RIPK4 | 0.64028963 |
| 93 | HIPK2 | 0.63212226 |
| 94 | DAPK1 | 0.61893830 |
| 95 | PDGFRA | 0.61381830 |
| 96 | DAPK3 | 0.58943464 |
| 97 | RPS6KC1 | 0.57394638 |
| 98 | RPS6KL1 | 0.57394638 |
| 99 | CSK | 0.57134275 |
| 100 | CDK9 | 0.57048437 |
| 101 | PRKAA2 | 0.56275929 |
| 102 | MET | 0.54546593 |
| 103 | PINK1 | 0.54332802 |
| 104 | MAP3K7 | 0.53960649 |
| 105 | TGFBR1 | 0.53585613 |
| 106 | MAPK4 | 0.53359547 |
| 107 | MAP2K2 | 0.52716373 |
| 108 | EPHB1 | 0.52512762 |
| 109 | ERBB2 | 0.52225044 |
| 110 | PIM1 | 0.51658003 |
| 111 | RPS6KA2 | 0.50468694 |
| 112 | IRAK3 | 0.50003356 |
| 113 | PRKD2 | 0.49087828 |
| 114 | FES | 0.48622116 |
| 115 | LCK | 0.48613388 |
| 116 | PRKAA1 | 0.48053810 |
| 117 | BRSK2 | 0.47691796 |
| 118 | CSNK1G1 | 0.47206550 |
| 119 | MAPKAPK2 | 0.46421307 |
| 120 | PTK2 | 0.46387661 |
| 121 | TBK1 | 0.46208350 |
| 122 | LYN | 0.45781087 |
| 123 | CSF1R | 0.44441956 |
| 124 | DYRK1B | 0.43889750 |
| 125 | CLK1 | 0.43432427 |
| 126 | SCYL2 | 0.43394931 |
| 127 | SIK3 | 0.43164726 |
| 128 | MAP3K5 | 0.42534983 |
| 129 | TAOK2 | 0.42425682 |
| 130 | BRAF | 0.42414070 |
| 131 | CHUK | 0.42277818 |
| 132 | GSK3A | 0.40604006 |
| 133 | PDK4 | 0.39645391 |
| 134 | PDK3 | 0.39645391 |
| 135 | CCNB1 | 0.39138588 |
| 136 | AKT2 | 0.38827959 |
| 137 | ATR | 0.38767734 |
| 138 | TNK2 | 0.38665600 |
| 139 | PAK1 | 0.38569931 |
| 140 | RPS6KA6 | 0.38254356 |
| 141 | MAP4K1 | 0.37919172 |
| 142 | CDK8 | 0.37799481 |
| 143 | IRAK1 | 0.36825194 |
| 144 | TIE1 | 0.36778936 |
| 145 | CHEK2 | 0.36710259 |
| 146 | AKT3 | 0.36386468 |
| 147 | CSNK2A2 | 0.36244294 |
| 148 | HCK | 0.35528932 |
| 149 | PAK4 | 0.34860406 |
| 150 | PASK | 0.34856856 |
| 151 | MAPK15 | 0.34394926 |
| 152 | STK4 | 0.33309822 |
| 153 | PAK2 | 0.32525559 |
| 154 | CSNK1G3 | 0.30062773 |
| 155 | CHEK1 | 0.29020403 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.25490410 |
| 2 | Other glycan degradation_Homo sapiens_hsa00511 | 3.54045803 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.24770860 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.13428109 |
| 5 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.09004930 |
| 6 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.87299172 |
| 7 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.79177336 |
| 8 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.74971989 |
| 9 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.55007607 |
| 10 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.46071351 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.38770074 |
| 12 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.37017042 |
| 13 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.33482008 |
| 14 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.31271436 |
| 15 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.20723174 |
| 16 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.14324362 |
| 17 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.10006563 |
| 18 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 2.04280160 |
| 19 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.03885052 |
| 20 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.02575524 |
| 21 | Peroxisome_Homo sapiens_hsa04146 | 2.01527928 |
| 22 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.99869447 |
| 23 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.96423393 |
| 24 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.89680788 |
| 25 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.86419022 |
| 26 | Leishmaniasis_Homo sapiens_hsa05140 | 1.86137995 |
| 27 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.85889995 |
| 28 | Allograft rejection_Homo sapiens_hsa05330 | 1.84321727 |
| 29 | Lysosome_Homo sapiens_hsa04142 | 1.81690078 |
| 30 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.81683170 |
| 31 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.80956808 |
| 32 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.80205548 |
| 33 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.75427168 |
| 34 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.75248190 |
| 35 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.73998696 |
| 36 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.73472994 |
| 37 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.72946434 |
| 38 | Histidine metabolism_Homo sapiens_hsa00340 | 1.70363548 |
| 39 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.68700985 |
| 40 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.68258980 |
| 41 | Asthma_Homo sapiens_hsa05310 | 1.68102507 |
| 42 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.67666073 |
| 43 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.66959069 |
| 44 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.64526544 |
| 45 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.64194602 |
| 46 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.63252885 |
| 47 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.62510495 |
| 48 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.56345797 |
| 49 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.55649680 |
| 50 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.55065151 |
| 51 | Retinol metabolism_Homo sapiens_hsa00830 | 1.51836521 |
| 52 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.51796549 |
| 53 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.49997951 |
| 54 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.46883664 |
| 55 | Sulfur relay system_Homo sapiens_hsa04122 | 1.45024223 |
| 56 | Influenza A_Homo sapiens_hsa05164 | 1.43124590 |
| 57 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.42853848 |
| 58 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.42568868 |
| 59 | Shigellosis_Homo sapiens_hsa05131 | 1.40716239 |
| 60 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.39077295 |
| 61 | Malaria_Homo sapiens_hsa05144 | 1.38781646 |
| 62 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.38645867 |
| 63 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.38112056 |
| 64 | Pertussis_Homo sapiens_hsa05133 | 1.37510817 |
| 65 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.36803069 |
| 66 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.35414368 |
| 67 | Viral myocarditis_Homo sapiens_hsa05416 | 1.35004229 |
| 68 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.34875440 |
| 69 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.34512245 |
| 70 | * Folate biosynthesis_Homo sapiens_hsa00790 | 1.31318019 |
| 71 | Carbon metabolism_Homo sapiens_hsa01200 | 1.30028627 |
| 72 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.29862734 |
| 73 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.28300853 |
| 74 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.28106936 |
| 75 | Salmonella infection_Homo sapiens_hsa05132 | 1.26339696 |
| 76 | Tuberculosis_Homo sapiens_hsa05152 | 1.26270230 |
| 77 | Apoptosis_Homo sapiens_hsa04210 | 1.25423820 |
| 78 | Bile secretion_Homo sapiens_hsa04976 | 1.25030494 |
| 79 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.18024799 |
| 80 | Measles_Homo sapiens_hsa05162 | 1.15603642 |
| 81 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.12569017 |
| 82 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.12304041 |
| 83 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.12293163 |
| 84 | Hepatitis B_Homo sapiens_hsa05161 | 1.11654117 |
| 85 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.10955881 |
| 86 | Hepatitis C_Homo sapiens_hsa05160 | 1.09822135 |
| 87 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.08818240 |
| 88 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.06561482 |
| 89 | Legionellosis_Homo sapiens_hsa05134 | 1.06494454 |
| 90 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.05344345 |
| 91 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.05180155 |
| 92 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.03332843 |
| 93 | ABC transporters_Homo sapiens_hsa02010 | 1.01352938 |
| 94 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.99028085 |
| 95 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.98263687 |
| 96 | HTLV-I infection_Homo sapiens_hsa05166 | 0.95930856 |
| 97 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.94628311 |
| 98 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.93627527 |
| 99 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.92905766 |
| 100 | Lysine degradation_Homo sapiens_hsa00310 | 0.92319556 |
| 101 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.92015374 |
| 102 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.90396909 |
| 103 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.87654863 |
| 104 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.86737210 |
| 105 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.85223342 |
| 106 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.84935471 |
| 107 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.84676619 |
| 108 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.82145273 |
| 109 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.81662353 |
| 110 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.81614373 |
| 111 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.80613766 |
| 112 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.79803825 |
| 113 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.78268958 |
| 114 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.71294929 |
| 115 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.70895160 |
| 116 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.70243195 |
| 117 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.69356574 |
| 118 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.68506757 |
| 119 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.63968189 |
| 120 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.62436782 |
| 121 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.61598142 |
| 122 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.60632446 |
| 123 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.60213589 |
| 124 | Amoebiasis_Homo sapiens_hsa05146 | 0.58935974 |
| 125 | Phagosome_Homo sapiens_hsa04145 | 0.58415903 |
| 126 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.56837499 |
| 127 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.55868181 |
| 128 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.53976578 |
| 129 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.53245997 |
| 130 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.47348692 |
| 131 | Spliceosome_Homo sapiens_hsa03040 | 0.46440373 |
| 132 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.42912122 |
| 133 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.42017232 |
| 134 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.41718010 |
| 135 | Galactose metabolism_Homo sapiens_hsa00052 | 0.41119970 |
| 136 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.40303677 |
| 137 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.37762137 |
| 138 | DNA replication_Homo sapiens_hsa03030 | 0.37414282 |
| 139 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.37048760 |
| 140 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.36086715 |
| 141 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.35700247 |
| 142 | Endocytosis_Homo sapiens_hsa04144 | 0.35645268 |
| 143 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.34553458 |
| 144 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.31424529 |
| 145 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.30874214 |
| 146 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.30192622 |
| 147 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.29620797 |
| 148 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.27151434 |
| 149 | Prion diseases_Homo sapiens_hsa05020 | 0.21693283 |
| 150 | Insulin resistance_Homo sapiens_hsa04931 | 0.20104167 |
| 151 | Mismatch repair_Homo sapiens_hsa03430 | 0.16172588 |
| 152 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.15768416 |
| 153 | Base excision repair_Homo sapiens_hsa03410 | 0.14714378 |
| 154 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.14403814 |
| 155 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.14377571 |
| 156 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.13297207 |
| 157 | RNA transport_Homo sapiens_hsa03013 | 0.13075409 |
| 158 | Proteasome_Homo sapiens_hsa03050 | 0.07148392 |
| 159 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.06728738 |
| 160 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.05447266 |
| 161 | RNA polymerase_Homo sapiens_hsa03020 | 0.03161855 |
| 162 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.03007496 |
| 163 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.02316789 |
| 164 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.0679908 |
| 165 | p53 signaling pathway_Homo sapiens_hsa04115 | -0.0644384 |
| 166 | RNA degradation_Homo sapiens_hsa03018 | -0.0550126 |
| 167 | Purine metabolism_Homo sapiens_hsa00230 | -0.0535007 |
| 168 | Homologous recombination_Homo sapiens_hsa03440 | -0.0360864 |
| 169 | Ribosome_Homo sapiens_hsa03010 | -0.0231348 |
| 170 | Bladder cancer_Homo sapiens_hsa05219 | -0.0140484 |
| 171 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.0019272 |

